HEADER TRANSFERASE 05-SEP-14 4UZD TITLE SAR156497 AN EXQUISITELY SELECTIVE INHIBITOR OF AURORA KINASES COMPND MOL_ID: 1; COMPND 2 MOLECULE: AURORA KINASE A; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 125-399; COMPND 5 SYNONYM: AURORA 2, AURORA/IPL1-RELATED KINASE 1, ARK-1, AURORA- COMPND 6 RELATED KINASE 1, HARK1, BREAST TUMOR-AMPLIFIED KINASE, COMPND 7 SERINE/THREONINE-PROTEIN KINASE 15, SERINE/THREONINE-PROTEIN KINASE COMPND 8 6, SERINE/THREONINE-PROTEIN KINASE AURORA-A; COMPND 9 EC: 2.7.11.1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.POUZIEUX,L.DELARBRE,J.Y.CRENNE REVDAT 4 21-AUG-19 4UZD 1 REMARK REVDAT 3 21-JAN-15 4UZD 1 JRNL REVDAT 2 14-JAN-15 4UZD 1 REMARK REVDAT 1 19-NOV-14 4UZD 0 JRNL AUTH J.C.CARRY,F.F.CLERC,H.MINOUX,L.SCHIO,J.MAUGER,A.NAIR, JRNL AUTH 2 E.PARMANTIER,R.LE MOIGNE,C.DELORME,J.P.NICOLAS,A.KRICK, JRNL AUTH 3 P.Y.ABECASSIS,V.CROCQ-STUERGA,S.POUZIEUX,L.DELARBRE, JRNL AUTH 4 S.MAIGNAN,T.BERTRAND,K.BJERGARDE,N.MA,S.LACHAUD,H.GUIZANI, JRNL AUTH 5 R.LEBEL,G.DOERFLINGER,S.MONGET,S.PERRON,F.GASSE, JRNL AUTH 6 O.ANGOUILLANT-BONIFACE,B.J.FILOCHE-ROMME,M.MURER,S.GONTIER, JRNL AUTH 7 C.PREVOST,M.L.MONTEIRO,C.COMBEAU JRNL TITL SAR156497 AN EXQUISITELY SELECTIVE INHIBITOR OF AURORA JRNL TITL 2 KINASES. JRNL REF J.MED.CHEM. V. 58 362 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25369539 JRNL DOI 10.1021/JM501326K REMARK 2 REMARK 2 RESOLUTION. 3.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 78.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 16434 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.215 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.730 REMARK 3 FREE R VALUE TEST SET COUNT : 1270 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 3.20 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.42 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.61 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2956 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2598 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2701 REMARK 3 BIN R VALUE (WORKING SET) : 0.2577 REMARK 3 BIN FREE R VALUE : 0.2827 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.63 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 255 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4217 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 70 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 117.4 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 94.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -11.21790 REMARK 3 B22 (A**2) : -11.21790 REMARK 3 B33 (A**2) : 22.43590 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.707 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.423 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.914 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.868 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4397 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5943 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1577 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 98 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 700 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4397 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 535 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5088 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.59 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 18.64 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: IDEAL-DIST CONTACT TERM CONTACT SETUP. REMARK 3 ALL ATOMS HAVE CCP4 ATOM TYPE FROM LIBRARY REMARK 4 REMARK 4 4UZD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 05-SEP-14. REMARK 100 THE DEPOSITION ID IS D_1290061671. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID29 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9762 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16476 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.200 REMARK 200 RESOLUTION RANGE LOW (A) : 78.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.9 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.08000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 5.90 REMARK 200 R MERGE FOR SHELL (I) : 0.41000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 68.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4% PEG 4000, 50 MM HEPES PH 7, PH 7.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 68.96000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 137.92000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 137.92000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 68.96000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 124 REMARK 465 LYS A 125 REMARK 465 ARG A 126 REMARK 465 TRP A 277 REMARK 465 SER A 278 REMARK 465 VAL A 279 REMARK 465 HIS A 280 REMARK 465 ALA A 281 REMARK 465 PRO A 282 REMARK 465 SER A 283 REMARK 465 SER A 284 REMARK 465 LYS A 389 REMARK 465 PRO A 390 REMARK 465 SER A 391 REMARK 465 ASN A 392 REMARK 465 CYS A 393 REMARK 465 GLN A 394 REMARK 465 ASN A 395 REMARK 465 LYS A 396 REMARK 465 GLU A 397 REMARK 465 SER A 398 REMARK 465 ALA A 399 REMARK 465 ALA A 400 REMARK 465 ALA A 401 REMARK 465 ALA A 402 REMARK 465 LEU A 403 REMARK 465 GLU A 404 REMARK 465 HIS A 405 REMARK 465 HIS A 406 REMARK 465 HIS A 407 REMARK 465 HIS A 408 REMARK 465 HIS A 409 REMARK 465 HIS A 410 REMARK 465 MET B 124 REMARK 465 SER B 278 REMARK 465 VAL B 279 REMARK 465 HIS B 280 REMARK 465 ALA B 281 REMARK 465 PRO B 282 REMARK 465 SER B 283 REMARK 465 SER B 284 REMARK 465 PRO B 390 REMARK 465 SER B 391 REMARK 465 ASN B 392 REMARK 465 CYS B 393 REMARK 465 GLN B 394 REMARK 465 ASN B 395 REMARK 465 LYS B 396 REMARK 465 GLU B 397 REMARK 465 SER B 398 REMARK 465 ALA B 399 REMARK 465 ALA B 400 REMARK 465 ALA B 401 REMARK 465 ALA B 402 REMARK 465 LEU B 403 REMARK 465 GLU B 404 REMARK 465 HIS B 405 REMARK 465 HIS B 406 REMARK 465 HIS B 407 REMARK 465 HIS B 408 REMARK 465 HIS B 409 REMARK 465 HIS B 410 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 171 14.74 -67.63 REMARK 500 SER A 226 -36.58 72.70 REMARK 500 ARG A 286 109.73 63.77 REMARK 500 ASP A 307 -151.82 -135.81 REMARK 500 LEU A 364 46.88 -94.30 REMARK 500 LYS B 171 13.37 -66.80 REMARK 500 SER B 226 -36.47 72.25 REMARK 500 ASP B 307 -150.17 -135.21 REMARK 500 LEU B 364 45.78 -93.59 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QMN A 1389 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE QMN B 1390 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4UZH RELATED DB: PDB REMARK 900 SAR156497 AN EXQUISITELY SELECTIVE INHIBITOR OF AURORA KINASES DBREF 4UZD A 125 399 UNP O14965 AURKA_HUMAN 125 399 DBREF 4UZD B 125 399 UNP O14965 AURKA_HUMAN 125 399 SEQADV 4UZD MET A 124 UNP O14965 EXPRESSION TAG SEQADV 4UZD ALA A 400 UNP O14965 EXPRESSION TAG SEQADV 4UZD ALA A 401 UNP O14965 EXPRESSION TAG SEQADV 4UZD ALA A 402 UNP O14965 EXPRESSION TAG SEQADV 4UZD LEU A 403 UNP O14965 EXPRESSION TAG SEQADV 4UZD GLU A 404 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS A 405 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS A 406 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS A 407 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS A 408 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS A 409 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS A 410 UNP O14965 EXPRESSION TAG SEQADV 4UZD MET B 124 UNP O14965 EXPRESSION TAG SEQADV 4UZD ALA B 400 UNP O14965 EXPRESSION TAG SEQADV 4UZD ALA B 401 UNP O14965 EXPRESSION TAG SEQADV 4UZD ALA B 402 UNP O14965 EXPRESSION TAG SEQADV 4UZD LEU B 403 UNP O14965 EXPRESSION TAG SEQADV 4UZD GLU B 404 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS B 405 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS B 406 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS B 407 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS B 408 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS B 409 UNP O14965 EXPRESSION TAG SEQADV 4UZD HIS B 410 UNP O14965 EXPRESSION TAG SEQRES 1 A 287 MET LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY SEQRES 2 A 287 ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU SEQRES 3 A 287 ALA ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS SEQRES 4 A 287 VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU SEQRES 5 A 287 HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU SEQRES 6 A 287 ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS SEQRES 7 A 287 ASP ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO SEQRES 8 A 287 LEU GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS SEQRES 9 A 287 PHE ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU SEQRES 10 A 287 ALA ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE SEQRES 11 A 287 HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER SEQRES 12 A 287 ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL SEQRES 13 A 287 HIS ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR SEQRES 14 A 287 LEU ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET SEQRES 15 A 287 HIS ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU SEQRES 16 A 287 CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA SEQRES 17 A 287 ASN THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL SEQRES 18 A 287 GLU PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG SEQRES 19 A 287 ASP LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN SEQRES 20 A 287 ARG PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE SEQRES 21 A 287 THR ALA ASN SER SER LYS PRO SER ASN CYS GLN ASN LYS SEQRES 22 A 287 GLU SER ALA ALA ALA ALA LEU GLU HIS HIS HIS HIS HIS SEQRES 23 A 287 HIS SEQRES 1 B 287 MET LYS ARG GLN TRP ALA LEU GLU ASP PHE GLU ILE GLY SEQRES 2 B 287 ARG PRO LEU GLY LYS GLY LYS PHE GLY ASN VAL TYR LEU SEQRES 3 B 287 ALA ARG GLU LYS GLN SER LYS PHE ILE LEU ALA LEU LYS SEQRES 4 B 287 VAL LEU PHE LYS ALA GLN LEU GLU LYS ALA GLY VAL GLU SEQRES 5 B 287 HIS GLN LEU ARG ARG GLU VAL GLU ILE GLN SER HIS LEU SEQRES 6 B 287 ARG HIS PRO ASN ILE LEU ARG LEU TYR GLY TYR PHE HIS SEQRES 7 B 287 ASP ALA THR ARG VAL TYR LEU ILE LEU GLU TYR ALA PRO SEQRES 8 B 287 LEU GLY THR VAL TYR ARG GLU LEU GLN LYS LEU SER LYS SEQRES 9 B 287 PHE ASP GLU GLN ARG THR ALA THR TYR ILE THR GLU LEU SEQRES 10 B 287 ALA ASN ALA LEU SER TYR CYS HIS SER LYS ARG VAL ILE SEQRES 11 B 287 HIS ARG ASP ILE LYS PRO GLU ASN LEU LEU LEU GLY SER SEQRES 12 B 287 ALA GLY GLU LEU LYS ILE ALA ASP PHE GLY TRP SER VAL SEQRES 13 B 287 HIS ALA PRO SER SER ARG ARG THR THR LEU CYS GLY THR SEQRES 14 B 287 LEU ASP TYR LEU PRO PRO GLU MET ILE GLU GLY ARG MET SEQRES 15 B 287 HIS ASP GLU LYS VAL ASP LEU TRP SER LEU GLY VAL LEU SEQRES 16 B 287 CYS TYR GLU PHE LEU VAL GLY LYS PRO PRO PHE GLU ALA SEQRES 17 B 287 ASN THR TYR GLN GLU THR TYR LYS ARG ILE SER ARG VAL SEQRES 18 B 287 GLU PHE THR PHE PRO ASP PHE VAL THR GLU GLY ALA ARG SEQRES 19 B 287 ASP LEU ILE SER ARG LEU LEU LYS HIS ASN PRO SER GLN SEQRES 20 B 287 ARG PRO MET LEU ARG GLU VAL LEU GLU HIS PRO TRP ILE SEQRES 21 B 287 THR ALA ASN SER SER LYS PRO SER ASN CYS GLN ASN LYS SEQRES 22 B 287 GLU SER ALA ALA ALA ALA LEU GLU HIS HIS HIS HIS HIS SEQRES 23 B 287 HIS HET QMN A1389 35 HET QMN B1390 35 HETNAM QMN ETHYL (9S)-9-[3-(1H-BENZIMIDAZOL-2-YLOXY)PHENYL]-8-OXO- HETNAM 2 QMN 4,5,6,7,8,9-HEXAHYDRO-2H-PYRROLO[3,4-B]QUINOLINE-3- HETNAM 3 QMN CARBOXYLATE FORMUL 3 QMN 2(C27 H24 N4 O4) HELIX 1 1 ALA A 129 GLU A 131 5 3 HELIX 2 2 LYS A 166 LYS A 171 1 6 HELIX 3 3 VAL A 174 LEU A 188 1 15 HELIX 4 4 THR A 217 SER A 226 1 10 HELIX 5 5 ASP A 229 LYS A 250 1 22 HELIX 6 6 LYS A 258 GLU A 260 5 3 HELIX 7 7 ASP A 294 LEU A 296 5 3 HELIX 8 8 PRO A 297 GLU A 302 1 6 HELIX 9 9 GLU A 308 GLY A 325 1 18 HELIX 10 10 THR A 333 VAL A 344 1 12 HELIX 11 11 THR A 353 LEU A 364 1 12 HELIX 12 12 ASN A 367 ARG A 371 5 5 HELIX 13 13 MET A 373 GLU A 379 1 7 HELIX 14 14 HIS A 380 SER A 387 1 8 HELIX 15 15 ALA B 129 GLU B 131 5 3 HELIX 16 16 LYS B 166 LYS B 171 1 6 HELIX 17 17 VAL B 174 LEU B 188 1 15 HELIX 18 18 THR B 217 SER B 226 1 10 HELIX 19 19 ASP B 229 LYS B 250 1 22 HELIX 20 20 LYS B 258 GLU B 260 5 3 HELIX 21 21 LEU B 293 LEU B 296 5 4 HELIX 22 22 PRO B 297 GLU B 302 1 6 HELIX 23 23 GLU B 308 GLY B 325 1 18 HELIX 24 24 THR B 333 VAL B 344 1 12 HELIX 25 25 THR B 353 LEU B 364 1 12 HELIX 26 26 ASN B 367 ARG B 371 5 5 HELIX 27 27 MET B 373 HIS B 380 1 8 HELIX 28 28 HIS B 380 SER B 387 1 8 SHEET 1 AA 5 PHE A 133 LYS A 141 0 SHEET 2 AA 5 GLY A 145 GLU A 152 -1 O VAL A 147 N LEU A 139 SHEET 3 AA 5 PHE A 157 PHE A 165 -1 O PHE A 157 N GLU A 152 SHEET 4 AA 5 ARG A 205 LEU A 210 -1 O VAL A 206 N LEU A 164 SHEET 5 AA 5 LEU A 196 HIS A 201 -1 N TYR A 197 O ILE A 209 SHEET 1 AB 2 LEU A 262 LEU A 264 0 SHEET 2 AB 2 LEU A 270 ILE A 272 -1 O LYS A 271 N LEU A 263 SHEET 1 AC 2 THR A 287 THR A 288 0 SHEET 2 AC 2 GLY A 291 THR A 292 -1 O GLY A 291 N THR A 288 SHEET 1 BA 5 PHE B 133 LYS B 141 0 SHEET 2 BA 5 ASN B 146 GLU B 152 -1 O VAL B 147 N LEU B 139 SHEET 3 BA 5 PHE B 157 PHE B 165 -1 O PHE B 157 N GLU B 152 SHEET 4 BA 5 ARG B 205 LEU B 210 -1 O VAL B 206 N LEU B 164 SHEET 5 BA 5 LEU B 196 HIS B 201 -1 N TYR B 197 O ILE B 209 SHEET 1 BB 2 LEU B 262 LEU B 264 0 SHEET 2 BB 2 LEU B 270 ILE B 272 -1 O LYS B 271 N LEU B 263 SITE 1 AC1 14 LYS A 141 VAL A 147 ALA A 160 LYS A 162 SITE 2 AC1 14 LEU A 178 GLN A 185 LEU A 194 LEU A 208 SITE 3 AC1 14 LEU A 210 GLU A 211 TYR A 212 ALA A 213 SITE 4 AC1 14 ALA A 273 PHE A 275 SITE 1 AC2 13 LYS B 141 VAL B 147 ALA B 160 LYS B 162 SITE 2 AC2 13 LEU B 178 GLN B 185 LEU B 208 GLU B 211 SITE 3 AC2 13 TYR B 212 ALA B 213 GLY B 216 ALA B 273 SITE 4 AC2 13 PHE B 275 CRYST1 90.450 90.450 206.880 90.00 90.00 120.00 P 31 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011056 0.006383 0.000000 0.00000 SCALE2 0.000000 0.012766 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004834 0.00000 MTRIX1 1 1.000000 0.022000 -0.004000 -0.15300 1 MTRIX2 1 0.004000 -0.007000 1.000000 -68.94900 1 MTRIX3 1 0.022000 -1.000000 -0.007000 68.16900 1